Author

Jakob Benedict Seidelin

COVID-19 AND INFLAMMATORY BOWEL DISEASE: PREVALENCE, RELATIONSHIP WITH IMMUNOSUPPRESSIVE THERAPIES AND MENTAL WELL-BEING. A NATIONWIDE DANISH SURVEY
COVID-19 AND INFLAMMATORY BOWEL DISEASE: PREVALENCE, RELATIONSHIP WITH IMMUNOSUPPRESSIVE THERAPIES AND MENTAL WELL-BEING. A NATIONWIDE DANISH SURVEY

Jakob Benedict Seidelin  et al.

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE

Jakob Benedict Seidelin  et al.

EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE
EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE

Jakob Benedict Seidelin  et al.

PATIENTS WITH ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES DO NOT DIFFER FROM THOSE WITH ADULT-ONSET IN THEIR INITIAL PRESENTATION - FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)
PATIENTS WITH ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES DO NOT DIFFER FROM THOSE WITH ADULT-ONSET IN THEIR INITIAL PRESENTATION - FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)

Jakob Benedict Seidelin  et al.

PREDICTORS OF AN EARLY SEVERE DISEASE COURSE OF NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES- FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)
PREDICTORS OF AN EARLY SEVERE DISEASE COURSE OF NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES- FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)

Jakob Benedict Seidelin  et al.

DISEASE ACTIVITY PATTERNS OF INFLAMMATORY BOWEL DISEASE - A DANISH NATIONWIDE COHORT STUDY 1995-2018
DISEASE ACTIVITY PATTERNS OF INFLAMMATORY BOWEL DISEASE - A DANISH NATIONWIDE COHORT STUDY 1995-2018

Jakob Benedict Seidelin  et al.

SHOULD ALL PATIENTS WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES BE SCREENED FOR METABOLIC BONE DISEASE? RESULTS FROM A DANISH POPULATION-BASED INCEPTION COHORT STUDY
SHOULD ALL PATIENTS WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES BE SCREENED FOR METABOLIC BONE DISEASE? RESULTS FROM A DANISH POPULATION-BASED INCEPTION COHORT STUDY

Jakob Benedict Seidelin  et al.

METABOLIC PROFILING OF COLONIC MUCOSAL WOUND HEALING IN ULCERATIVE COLITIS MAY LEAD TO NOVEL THERAPEUTIC OPTIONS
METABOLIC PROFILING OF COLONIC MUCOSAL WOUND HEALING IN ULCERATIVE COLITIS MAY LEAD TO NOVEL THERAPEUTIC OPTIONS

Jakob Benedict Seidelin  et al.

COMPARATIVE EFFICACY OF ADVANCED THERAPIES FOR FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
COMPARATIVE EFFICACY OF ADVANCED THERAPIES FOR FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Jakob Benedict Seidelin  et al.

PROBIOTIC TREATMENT OF ULCERATIVE COLITIS WITH TRICHURIS SUIS OVA: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED CLINICAL TRIAL
PROBIOTIC TREATMENT OF ULCERATIVE COLITIS WITH TRICHURIS SUIS OVA: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED CLINICAL TRIAL

Jakob Benedict Seidelin  et al.

TIME TO EFFECT OF BIOLOGICS AND SMALL MOLECULES IN MODERATELY TO SEVERELY ACTIVE LUMINAL CROHN’S DISEASE – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
TIME TO EFFECT OF BIOLOGICS AND SMALL MOLECULES IN MODERATELY TO SEVERELY ACTIVE LUMINAL CROHN’S DISEASE – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Jakob Benedict Seidelin  et al.

RESPONSE TO INDUCTION TREATMENT WITH BIOLOGICALS IN A MULTICENTER, PROSPECTIVE COHORT OF BIOLOGICAL-NAïVE IBD PATIENTS - PRELIMINARY RESULTS FROM THE DANISH IBD BIOBANK PROJECT
RESPONSE TO INDUCTION TREATMENT WITH BIOLOGICALS IN A MULTICENTER, PROSPECTIVE COHORT OF BIOLOGICAL-NAïVE IBD PATIENTS - PRELIMINARY RESULTS FROM THE DANISH IBD BIOBANK PROJECT

Jakob Benedict Seidelin  et al.

A POPULATION-BASED STUDY ON COVID-19 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES: PRELIMINARY RESULTS FROM THE DANISH COVID-IBD DATABASE
A POPULATION-BASED STUDY ON COVID-19 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES: PRELIMINARY RESULTS FROM THE DANISH COVID-IBD DATABASE

Jakob Benedict Seidelin  et al.

INTESTINAL ULTRASOUND IS RESPONSIVE TO TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE
INTESTINAL ULTRASOUND IS RESPONSIVE TO TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE

Jakob Benedict Seidelin  et al.

PERIPHERAL JOINT AND ENTHESIS INVOLVEMENT IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): SYMPTOMS, CLINICAL AND ULTRASONOGRAPHIC FINDINGS
PERIPHERAL JOINT AND ENTHESIS INVOLVEMENT IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): SYMPTOMS, CLINICAL AND ULTRASONOGRAPHIC FINDINGS

Jakob Benedict Seidelin  et al.

INTESTINAL ULTRASOUND AT IBD DIAGNOSIS PREDICTS MAJOR DISEASE EVENTS – A COPENHAGEN IBD COHORT STUDY
INTESTINAL ULTRASOUND AT IBD DIAGNOSIS PREDICTS MAJOR DISEASE EVENTS – A COPENHAGEN IBD COHORT STUDY

Jakob Benedict Seidelin  et al.

OUTCOMES OF FIRST-LINE BIOLOGICALS IN A MULTICENTER PROSPECTIVE COHORT OF BIOLOGICAL-NAÏVE IBD PATIENTS – THE DANISH IBD BIOBANK PROJECT
OUTCOMES OF FIRST-LINE BIOLOGICALS IN A MULTICENTER PROSPECTIVE COHORT OF BIOLOGICAL-NAÏVE IBD PATIENTS – THE DANISH IBD BIOBANK PROJECT

Jakob Benedict Seidelin  et al.

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY

Jakob Benedict Seidelin  et al.

VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Jakob Benedict Seidelin  et al.

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY
OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

Jakob Benedict Seidelin  et al.

Item 1 - 20 / 20
1